Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination.
Lee EJ, Cines DB, Gernsheimer T, Kessler C, Michel M, Tarantino MD, Semple JW, Arnold DM, Godeau B, Lambert MP, Bussel JB. Lee EJ, et al. Among authors: tarantino md. Am J Hematol. 2021 May 1;96(5):534-537. doi: 10.1002/ajh.26132. Epub 2021 Mar 9. Am J Hematol. 2021. PMID: 33606296 Free PMC article. No abstract available.
The child with immune thrombocytopenic purpura: is pharmacotherapy or watchful waiting the best initial management? A panel discussion from the 2002 meeting of the American Society of Pediatric Hematology/Oncology.
Bolton-Maggs P, Tarantino MD, Buchanan GR, Bussel JB, George JN; American Society of Pediatric Hematology/Oncology. Bolton-Maggs P, et al. Among authors: tarantino md. J Pediatr Hematol Oncol. 2004 Feb;26(2):146-51. doi: 10.1097/00043426-200402000-00020. J Pediatr Hematol Oncol. 2004. PMID: 14767210
Review of therapies for immune thrombocytopenic purpura.
Bussel J, Tarantino M. Bussel J, et al. Semin Hematol. 2006 Jul;43(3 Suppl 5):S1-2. doi: 10.1053/j.seminhematol.2006.04.010. Semin Hematol. 2006. PMID: 16815344 Review. No abstract available.
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial.
Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, Aledort LM, George JN, Kessler CM, Sanz MA, Liebman HA, Slovick FT, de Wolf JT, Bourgeois E, Guthrie TH Jr, Newland A, Wasser JS, Hamburg SI, Grande C, Lefrère F, Lichtin AE, Tarantino MD, Terebelo HR, Viallard JF, Cuevas FJ, Go RS, Henry DH, Redner RL, Rice L, Schipperus MR, Guo DM, Nichol JL. Kuter DJ, et al. Among authors: tarantino md. Lancet. 2008 Feb 2;371(9610):395-403. doi: 10.1016/S0140-6736(08)60203-2. Lancet. 2008. PMID: 18242413 Clinical Trial.
International consensus report on the investigation and management of primary immune thrombocytopenia.
Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ. Provan D, et al. Blood. 2010 Jan 14;115(2):168-86. doi: 10.1182/blood-2009-06-225565. Epub 2009 Oct 21. Blood. 2010. PMID: 19846889 Free article. Review.
RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME).
Despotovic JM, Lambert MP, Herman JH, Gernsheimer TB, McCrae KR, Tarantino MD, Bussel JB. Despotovic JM, et al. Among authors: tarantino md. Transfusion. 2012 May;52(5):1126-36; quiz 1125. doi: 10.1111/j.1537-2995.2011.03384.x. Epub 2011 Oct 7. Transfusion. 2012. PMID: 21981825 Free PMC article. Review.
105 results